“You have a pattern of inattention to human subjects protection requirements.”
— Kaiser Permanente’s Institutional Review Board, an independent committee required by law to ensure patient safety in clinical studies, to two Kaiser researchers whose test of a fish-oil derived drug’s effectiveness in treating respiratory illnesses was halted after an audit found some patients being tested had shellfish allergies and weren’t excluded, putting them at risk.